AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,969 | -99.9% | 99,211 | +3.2% | 0.05% | +6.0% |
| Q3 2022 | $1,909,000 | +5354.3% | 96,153 | +5317.1% | 0.05% | +4900.0% |
| Q2 2022 | $35,000 | -22.2% | 1,775 | -22.8% | 0.00% | 0.0% |
| Q1 2022 | $45,000 | +1400.0% | 2,300 | +338.1% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 525 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 525 | +40.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 375 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | – | 375 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $9,000 | – | 2,000 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2018 | $128,000 | +36.2% | 5,748 | 0.0% | 0.01% | +25.0% |
| Q2 2018 | $94,000 | – | 5,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |